Prognostic value of immune-inflammation and nutritional indices in advanced hepatocellular carcinoma patients receiving immunotherapy with compound Kushen injection
The pretreatment SII-PNI score is an important indicator of treatment sensitivity for patients with advanced HCC receiving intraperitoneal CKI. It also represents a crucial basis for evaluating treatment efficacy and prognosis, aiding in the identification of high-risk groups and prognosis prediction.
Authors
- Suhang Zhang
- Yueyue Wu (ORCID: https://orcid.org/0000-0002-6237-3430)
- Yong Zhu (ORCID: https://orcid.org/0000-0002-0096-6564)
- Ming Zhang (ORCID: https://orcid.org/0000-0002-8879-1956)
- Dongwei Zhang (ORCID: https://orcid.org/0000-0002-7793-1482)
- Minghui Yu
Institutions
- Anhui Medical University (CN)
- Anhui University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-07-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i7.106684
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00